Showing 101 - 120 results of 223 for search '"irritable bowel syndrome"', query time: 0.07s Refine Results
  1. 101

    Subjective Taste and Smell Changes in Conjunction with Anxiety and Depression Are Associated with Symptoms in Patients with Functional Constipation and Irritable Bowel Syndrome by Jie Liu, Chaolan Lv, Dandan Wu, Ying Wang, Chenyu Sun, Ce Cheng, Yue Yu

    Published 2021-01-01
    “…Patients with functional constipation (FC) and irritable bowel syndrome (IBS) often report psychological abnormalities and decreased eating enjoyment. …”
    Get full text
    Article
  2. 102
  3. 103

    Efficacy of the Enteroadsorbent Silicol®gel in Adults with Irritable Bowel Syndrome Subtypes IBS-D or Mixed: Observational Open-Label Study by Gordon Crawford, Rory Taylor, David Young, Chris G. Hatton

    Published 2023-01-01
    “…Background. Irritable bowel syndrome (IBS) is a common chronic gut-brain interaction disorder with limited effective treatment options. …”
    Get full text
    Article
  4. 104

    Efficacy and Safety of a Novel Herbal Medicine in the Treatment of Irritable Bowel Syndrome: A Randomized Double-Blinded Clinical Trial by Ghasem Bordbar, Mohammad Bagher Miri, Mahmoud Omidi, Saeed Shoja, Malihe Akhavan

    Published 2020-01-01
    “…The unresponsiveness to conventional pharmacological treatments and their side effects have led patients with irritable bowel syndrome (IBS) to use complementary and alternative medicine such as herbal remedies. …”
    Get full text
    Article
  5. 105
  6. 106

    Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study by Yinglian Xiao, Xianmei Meng, Qingfeng Luo, Xiaohua Hou, Jie Jin, Xianfei Zhong, Wei Gong, Xiuling Li, Minhu Chen

    Published 2025-02-01
    “…Background: Linaclotide, a guanylate cyclase-C agonist, is indicated for irritable bowel syndrome with constipation (IBS-C). However, real-world data on the safety and patient-reported outcomes (PROs) of linaclotide are scarce in Chinese patients with IBS-C. …”
    Get full text
    Article
  7. 107

    Prevalence and Associated Risk Factors of Irritable Bowel Syndrome Among Female Secondary School students in Ar Rass City, Qassim Region by Wjdan Alharbi, Saulat Jahan

    Published 2022-05-01
    “…# Background Irritable bowel syndrome (IBS) is a common chronic gastrointestinal condition associated with many modifiable and non-modifiable risk factors…”
    Get full text
    Article
  8. 108
  9. 109

    Efficacy of drugs most commonly prescribed at functional gastrointestinal diseases (functional dyspepsia syndrome and irritable bowel syndrome) observational study results by V. T. Ivashkin, Ye. A. Poluektova, D. V. Reykhart, O. S. Shifrin, A. G. Beniashvili, O. S. Lyashenko, A. V. Belostotsky

    Published 2018-08-01
    “…To define efficacy of these agents according to results of «7×7» questionnaire (7 symptoms per 7 days) at treatment of functional dyspepsia (FD), irritable bowel syndrome (IBS) and combination of these diseases. …”
    Get full text
    Article
  10. 110
  11. 111
  12. 112
  13. 113
  14. 114
  15. 115
  16. 116

    A Conservative Weight Loss Intervention Relieves Bowel Symptoms in Morbidly Obese Subjects with Irritable Bowel Syndrome: A Prospective Cohort Study by Martin Aasbrenn, Stian Lydersen, Per G. Farup

    Published 2018-01-01
    “…Background. Irritable bowel syndrome (IBS) is common in subjects with morbid obesity; the effect of weight loss programs on bowel symptoms is largely unknown. …”
    Get full text
    Article
  17. 117

    Abdominal Massage Improves the Symptoms of Irritable Bowel Syndrome by Regulating Mast Cells via the Trypase-PAR2-PKCε Pathway in Rats by Huanan Li, Wei Zhang, Fei Ma, Xiaofan Zhang, Yuyan Wang, Jingui Wang

    Published 2022-01-01
    “…Background. Irritable bowel syndrome (IBS) is a clinical disease mainly characterized as a syndrome of abdominal pain and discomfort, which frequently occurs in humans aged 20–50. …”
    Get full text
    Article
  18. 118

    Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT) by Ansgar W Lohse, Bernd Löwe, Kerstin Maehder, Yvonne Nestoriuc, Antonia Zapf, Eik Vettorazzi, Viola Andresen, Sina Hübener, Luisa Peters

    Published 2022-06-01
    “…Introduction Ulcerative colitis (UC) and irritable bowel syndrome (IBS) are distressing chronic diseases associated with abdominal pain and altered bowel habits of unknown aetiology. …”
    Get full text
    Article
  19. 119
  20. 120